Phase 2 Trials The findings of phase 1 studies supported the continued clinical development of retatrutide as a promising candidate for the treatment of obesity and T2D
Neutrophil extracellular traps in rheumatoid arthritis: pathogenic mechanisms and therapeutic potential
549,550,551,552,553 Single-cell RNA sequencing revealed a significant reduction in astrocytes in AD mice, with ferroptosis activated in astrocytes, and FTH1 in astrocytes was identified as a hub gene associated with ferroptosis
Evidence suggests that people who test positive for glial inflammation (aka astrocyte reactivity) as well as plaque formations are the most predisposed to progress toward symptoms of cognitive decline (2b)
We closely follow the latest clinical trials and studies on the medications we recommend, including semaglutide
Samples were separated on a 12% SDS-PAGE gel and transferred onto a nitrocellulose membrane